3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Carcinoma, Renal Cell
2
Uterine Prolapse
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Ovarian Neoplasms
1
Metrorrhagia
1
Hemorrhage
1
Fallopian Tube Neoplasms
1
Endometriosis
1
Endometrial Neoplasms
1
Interventions
Paclitaxel
6
pembrolizumab
3
Cisplatin
3
Carboplatin
3
Biopsy
3
adavosertib
2
Trastuzumab
2
Magnetic Resonance Spectroscopy
2
Fulvestrant
2
Doxorubicin
2
ulixertinib
1
tucatinib
1
trastuzumab deruxtecan
1
trastuzumab biosimilar HLX02
1
trametinib
1
selinexor
1
sapanisertib
1
sacituzumab govitecan
1
relugolix
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
niraparib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
dostarlimab
1
dehydroftorafur
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Sutures
×
1 year
×
Clear all
NCT06024109
2026-06-02
BARHYSTER
Aesculap AG
Recruiting
132 enrolled